A Study of Yervoy and Opdivo Combination Therapy in Participants With Unresectable Advanced/Recurrent Malignant Pleural Mesothelioma (MPM)
Condition:   Mesothelioma, Malignant Intervention:   Sponsor:   Bristol-Myers Squibb Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 12, 2022 Category: Research Source Type: clinical trials

Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors
Conditions:   Pancreatic Cancer;   Breast Cancer;   Gastric Cancer;   Non Small Cell Lung Cancer;   Cervical Cancer;   Endocervical Cancer;   Squamous Cell Carcinoma of Head and Neck;   Bladder Urothelial Cancer;   Colorectal Cancer;   Esophageal Cancer;   Ovarian Cancer;   Rena l Cell Carcinoma;   Prostate Cancer;   Melanoma;   Mesothelioma;   Cholangiocarcinoma Interventions:   Drug: NGM438;   Drug: NGM438 plus pembrolizumab Sponsor:   NGM Biopharmaceuticals, Inc Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2022 Category: Research Source Type: clinical trials